Evidence map›Paper›PMID 33034008›Full record

ArticleJournal of computer-aided molecular design2021

Machine learning-accelerated quantum mechanics-based atomistic simulations for industrial applications.

Tobias Morawietz, Nongnuch Artrith

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Open-Source Machine Learning in Computational Chemistry.Journal of chemical information and modeling · 2023
    Review
  7. Structure-basedComputational and structural biotechnology journal · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tobias MorawietzBayer AG, Pharmaceuticals, R&D, Digital Technologies, Computational Molecular Design, 42096, Wuppertal, Germany.ORCID 0000-0002-9385-8721
Nongnuch ArtrithDepartment of Chemical Engineering, Columbia University, New York, NY, 10027, USA. nartrith@atomistic.net.ORCID 0000-0003-1153-6583

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atomistic simulations have become an invaluable tool for industrial applications ranging from the optimization of protein-ligand interactions for drug discovery to the design of new materials for energy applications. Here we review recent advances in the use of machine learning (ML) methods for accelerated simulations based on a quantum mechanical (QM) description of the system. We show how recent progress in ML methods has dramatically extended the applicability range of conventional QM-based simulations, allowing to calculate industrially relevant properties with enhanced accuracy, at reduced computational cost, and for length and time scales that would have otherwise not been accessible. We illustrate the benefits of ML-accelerated atomistic simulations for industrial R&D processes by showcasing relevant applications from two very different areas, drug discovery (pharmaceuticals) and energy materials. Writing from the perspective of both a molecular and a materials modeling scientist, this review aims to provide a unified picture of the impact of ML-accelerated atomistic simulations on the pharmaceutical, chemical, and materials industries and gives an outlook on the exciting opportunities that could emerge in the future.

Indexed as

Drug DiscoveryMachine LearningQuantum TheoryDrug DesignLigandsModels, MolecularPharmaceutical PreparationsLigandsPharmaceutical PreparationsDrug discoveryEnergy materialsIndustrial applicationsMachine learningNeural networksQuantum mechanics

Identifiers

PMID33034008
PMCPMC8018928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.